Completed NA INTERVENTIONAL 2-arm NCT00400166

Recovery Guide Intervention for Recurrent Psychiatric Hospitalization

Sponsor: Connecticut State, Department of Mental Health and Addiction Services

Conditions Bipolar Disorder Psychotic Depression Schizoaffective Disorder Schizophrenia

Updated 5 times since 2017 Last updated: Jun 10, 2009 Started: Dec 31, 2006 Primary completion: May 31, 2009 Completion: May 31, 2009

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT00400166, this NA trial focuses on Bipolar Disorder and Psychotic Depression and remains completed. Sponsored by Connecticut State, Department of Mental Health and Addiction Services, it has been updated 5 times since 2006, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jun 2018 — Jan 2021 [monthly]

Completed NA
Jan 2017 — Jun 2018 [monthly]

Completed NA

First recorded

Dec 2006

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Connecticut State, Department of Mental Health and Addiction Services
Eli Lilly and Company
Yale University

Data source: Yale University

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• New Haven, United States